PlainRecalls
FDA Drug Moderate Class II Terminated

Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.

Reported: June 25, 2014 Initiated: May 16, 2014 #D-1386-2014

Product Description

Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.

Reason for Recall

Subpotent Drug.

Details

Recalling Firm
Actavis Inc
Units Affected
6913 packages
Distribution
U.S. Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.. Recalled by Actavis Inc. Units affected: 6913 packages.
Why was this product recalled?
Subpotent Drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 25, 2014. Severity: Moderate. Recall number: D-1386-2014.